Jaan-Olle Andressoo and his team at the University of Helsinki are working to develop a revolutionary new method for the treatment of Parkinson’s and other neurodegenerative diseases. Early results look extremely promising.
The predictability of cardiovascular diseases can be improved through research into intercellular communication. In a high-risk project funded by the Academy of Finland, a research team led by researcher Cecilia Sahlgren from Åbo Akademi University is studying the formation of blood vessels and looking for new blood vessel regulation mechanisms.
Growing a whole new tooth outside the body, artificially, is set to become reality in the not-too-distant future. Working with high-risk research funding from the Academy of Finland, University of Helsinki researcher Anamaria Balic is exploring means to grow whole teeth in vitro using dental stem cells.
A three-dimensional liver model under development may in the future be used to test the safety of pharmaceuticals and to develop personalised treatments for liver diseases. Led by University Researcher Yan-Ru Lou, the high-risk research project funded by the Academy of Finland aims to generate even better functional, three-dimensional liver organoids, or cell cultures, from human stem cells.
Cutting-edge research into nanomedicines could facilitate a faster development of new drug therapies and reduce the use of animals in research. Tapani Viitala, a researcher at the University of Helsinki and lead scientist of a project supported under a high-risk funding trial of the Academy of Finland, is investigating and developing novel cell-based in vitro methods to support the development of new medicines.
Our international, English-language newsletter will keep you updated on the Finnish world of science and research. Click here to subscribe.
The Academy will open a targeted call in response to the Government’s strategic key projects programme. The aim is to further strengthen research quality and impact. Click here to read more about the funding.
Academy Professor Markku Peltonen is fascinated by the similarities he finds between 17th-century newspapers and political pamphlets and the tone of messages posted on today’s social networking sites. As always, he says, studying history can teach us important lessons for the present day.
Register now for the 7th edition of the EU-India STI Cooperation Days - Bioeconomy – 21-22 September 2016, CSIR-NIO, Goa, India.
Register your joint international research project at the FinCEAL-Infobank and win a 1500 € travel grant. The competition is open until August 31st, 2016.
The Academy of Finland has decided to fund eight new research posts as Academy Professor. The new Academy Professors are Eero Castrén (University of Helsinki), Sara Heinämaa (University of Jyväskylä), Markku Kulmala (University of Helsinki), Matti Latva-aho (University of Oulu), Craig Primmer (University of Turku), Hannu Salmi (University of Turku), Päivi Törmä (Aalto University) and Anu Wartiovaara (University of Helsinki). Their five-year terms commence on 1 January 2017.
Earlier this year, the Academy of Finland made a few key changes to the eligibility requirements concerning its Postdoctoral Researcher and Academy Research Fellow funding schemes. Learn more and see the FAQ section here.
The Academy of Finland is set to implement major reforms to its Centre of Excellence programme. The goal is to have future programmes place greater focus on scientific regeneration, risk-taking opportunities and breakthrough research.
Academy Professor Elina Vuola’s ongoing research project represents a critical theological perspective on gender research. Her project involves interviewing Orthodox, Jewish and Skolt Sámi women in Finland in order to gain a more meaningful insight into questions of ethnicity, gender and religion.
Researchers in Finland are working to develop targeted drugs to act as neuroprotective agents in inflammatory brain diseases and neurodegenerative diseases. Heading a project funded under a high-risk funding trial, Academy Research Fellow Kristiina Huttunen is studying the role of prodrugs as an effective drug delivery method to cross the blood-brain barrier.
We actively cooperate with key funding agencies in the Nordic countries, in Europe and worldwide to ensure that Finnish researchers are in the best possible position to engage in high-standard international research collaboration. Read more about our international activities here.